Efficacy and safety of tacrolimus-based treatment for non-rapidly progressive IgA nephropathy
In this study, we aimed to evaluate the efficacy and safety of tacrolimus-based treatment for immunoglobulin A nephropathy (IgAN). We retrospectively reviewed 127 adult patients with primary IgAN with 24 h urine total protein quantity (24 h UTP) ≥ 1 g and serum creatinine ≤3 mg/dL. All patients were...
Saved in:
Main Authors: | Lijuan Zhao (Author), Yanyan Yang (Author), Hao Xu (Author), Wei Leng (Author), Guoshuang Xu (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2023-05-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Efficacy and Safety of Agents in IgA Nephropathy: An Update Network Meta-Analysis
by: Pingping Yang, et al.
Published: (2018) -
Research advances Progress in the pathogenesis of IgA nephropathy
by: Fei-fei Wang, et al.
Published: (2024) -
Treatment of rapidly progressive IgA nephropathy with glucocorticoid plus telitacicept: one case report
by: Jia-xin Huang, et al.
Published: (2024) -
Efficacy and safety of sequential immunosuppressive treatment for severe IgA nephropathy: A retrospective study
by: Mian-Na Luo, et al.
Published: (2023) -
Efficacy and Safety of Immunosuppressive Monotherapy Agents for IgA Nephropathy: A Network Meta-Analysis
by: Shisheng Han, et al.
Published: (2021)